Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycatsnews2025-04-16T14:43:02+00:00April 16th, 2025|The New York Times|
Trump’s Tariff Threat for Drug imports Poses Big Political Risksnews2025-04-15T14:33:12+00:00April 15th, 2025|The New York Times|
Trump’s Next Tariffs Target Could be Foreign-Made Pharmaceuticalsnews2025-04-04T09:00:28+00:00April 4th, 2025|The New York Times|
Lo que hay que saber sobre el Adderall, Ritalin y otros estimulantesnews2025-03-31T09:04:11+00:00March 31st, 2025|The New York Times|
What to Know About Adderall, Ritalin and Other Prescription Stimulantsnews2025-03-27T09:02:19+00:00March 27th, 2025|The New York Times|
U.S. Races to Replace IV Fluid Supplies After Hurricane Helenenews2024-10-09T22:48:57+00:00October 9th, 2024|The New York Times|
Mounjaro and Zepbound Are No Longer in Shortage, F.D.A. Saysnews2024-10-03T16:50:39+00:00October 3rd, 2024|The New York Times|
The Global Threat of Antibiotic Resistancenews2024-09-26T21:02:21+00:00September 26th, 2024|The New York Times|
Vyvanse Production Increased by D.E.A. Amid A.D.H.D. Medication Shortagenews2024-09-06T18:26:10+00:00September 6th, 2024|The New York Times|
La viruela del mono en la República Democrática del Congo se enfrenta sin vacunasnews2024-09-01T18:23:30+00:00September 1st, 2024|The New York Times|
